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Background: The objective of the prevention of Mother-to-Child Transmission (pMTCT) cascade analysis tool is to
provide frontline health managers at the facility level with the means to rapidly, independently and quantitatively
track patient flows through the pMTCT cascade, and readily identify priority areas for clinic-level improvement
interventions. Over a period of six months, five experienced maternal-child health managers and researchers
iteratively adapted and tested this systems analysis tool for pMTCT services. They prioritized components of the
pMTCT cascade for inclusion, disseminated multiple versions to 27 health managers and piloted it in five facilities.
Process mapping techniques were used to chart PMTCT cascade steps in these five facilities, to document antenatal
care attendance, HIV testing and counseling, provision of prophylactic anti-retrovirals, safe delivery, safe infant
feeding, infant follow-up including HIV testing, and family planning, in order to obtain site-specific knowledge of
service delivery.
Results: Seven pMTCT cascade steps were included in the Excel-based final tool. Prevalence calculations were
incorporated as sub-headings under relevant steps. Cells not requiring data inputs were locked, wording was
simplified and stepwise drop-offs and maximization functions were included at key steps along the cascade.
While the drop off function allows health workers to rapidly assess how many patients were lost at each step, the
maximization function details the additional people served if only one step improves to 100% capacity while others
stay constant.
Conclusions: Our experience suggests that adaptation of a cascade analysis tool for facility-level pMTCT services is
feasible and appropriate as a starting point for discussions of where to implement improvement strategies. The
resulting tool facilitates the engagement of frontline health workers and managers who fill out, interpret, apply the
tool, and then follow up with quality improvement activities. Research on adoption, interpretation, and sustainability
of this pMTCT cascade analysis tool by frontline health managers is needed.
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Prevention of mother-to-child transmission (pMTCT)
using antiretroviral prophylaxis is a proven, efficacious
intervention, and can reduce vertical HIV transmission
to less than 2% [1-3] In practice however, gaps along the
pMTCT care cascade diminish pMTCT effectiveness in
resource-limited settings.
The pMTCTcascade represents a complex system of se-
quential, interdependent steps that pregnant HIV-infected
women pass through in order to receive appropriate care
and treatment for themselves and their newborns. The se-
quential pMTCT ‘cascade’ typically includes antenatal care
(ANC) attendance, HIV counseling and testing, prophylac-
tic antiretroviral medicines (ARVs), safe delivery, safe in-
fant feeding, infant follow-up including HIV testing, and
family planning [4,5]. The pMTCT cascade may also in-
clude women’s linkages into long-term HIV care and
treatment services, including assessment for combin-
ation antiretroviral therapy (cART) and cART initiation.
Mozambique’s pMTCT cascade performance is similar
to many resource-limited settings with a high HIV
burden. HIV testing in ANC is high (estimated at 87%
among ANC attendees), while maternal access to ARV
prophylaxis and cART for eligible women and newborns
remains low (51% and 42%, respectively) [6,7]. Infant
feeding practices, low post-partum use of modern family
planning methods, weak linkages with HIV care, and
sub-optimal integration with other effective ANC services
further impede pMTCT effectiveness in Mozambique. As
a result, pediatric HIV infection remains high in the coun-
try, with HIV transmission occurring in an estimated 28%
of babies born to HIV-infected women [7]. The high rate
of MTCT in Mozambique highlights the urgent need to
improve the delivery of efficacious interventions to preg-
nant women and their infants.
Quality improvement (QI) has been highlighted as an
approach to bridge the gap between evidence-based know-
ledge and its application to improve health outcomes
[8,9]. QI has been broadly applied in high resource health
systems, and is increasingly being utilized in resource-
limited settings, including maternal and child health ser-
vices. QI has recently been applied to pMTCT [10], data
quality [11,12], continuous monitoring and performance
improvement [12,13], strengthening community/health
facility linkages, and strengthening the coordination of
non-governmental organizations (NGOs) [14]. However,
typically QI for pMTCT has relied on time and resource
intensive peer-to-peer exchange, training, and expert
mentoring to successfully highlight delivery bottlenecks,
identify workflow modifications to address these bottle-
necks, and evaluate the impact of these innovations
[12,13,15,16]. Other studies have used quantitative ana-
lysis to assess the flow of patients through HIV services
to highlight where to intervene for improvement efforts,though the complexity of the analysis procedures limits
their use by clinic-level health workers [17,18]. Simple
strategies and tools to support heath authorities to inde-
pendently conduct QI for pMTCT – including assessing
where to intervene along the pMTCT cascade – are also
needed to expand QI efforts and improve service effect-
iveness and program ownership. Specifically, a compre-
hensive systems view enables effective, evidence-based
decision-making among managers and frontline health
workers, including the identification of bottlenecks, and
the definition and implementation of appropriate solu-
tions to improve their system [19].
Use of routine health management information systems
(HMIS) for decision-making has been difficult in resource-
limited settings, including for pMTCT [18,20,21], partially
due to lack of investment in HMIS quality [11]. Efforts to
improve the quality of routine HMIS and stimulate its use
by health system managers include periodic data audits
[11,18,22,23], the collection of fewer, streamlined indicators
[24], and developing tools, such as the pMTCT cascade
analysis tool (PCAT) tailored to the needs and competen-
cies of health facility managers and frontline health workers
to foster their active engagement with their data.
The objective of this paper is to introduce the process
for developing a rapid, simple approach to support health
facility managers to use routine HMIS data to assess facil-
ity performance across the pMTCT cascade as a first step
in identifying where in the pMTCT cascade to intervene
to maximize improvements in overall pMTCT delivery. In
addition, this paper will address the selection of specific
data content for the tool, which aims to increase health
workers’ overall understanding of their health system




The overall objective of the pMTCT cascade analysis tool
(PCAT) is to provide frontline MCH health managers at
the health facility level with the means to rapidly, inde-
pendently and quantitatively track patient flows through
the pMTCT cascade, and readily identify priority areas for
clinic-level improvement interventions.
Setting
The PCAT was developed, piloted, and refined over a
6-month period in Beira city, the capital of Sofala
Province, central Mozambique (Figure 1). Beira is a large
port city (population 470,000) [25], with a high HIV bur-
den (estimated at 17.8%) [26]. In the Mozambique health
system, maternal and child health (MCH) nurses are re-
sponsible for the management and delivery of pMTCT
services across the pregnancy, birth and post-partum
periods.
Mozambique
Figure 1 Map of Sofala Province, Mozambique.
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Over a four-week period beginning in January, 2013, a
group of 5 experienced MCH program managers and re-
searchers met weekly to adapt an HIV care cascade tool
for the pMTCT cascade [17]. This original tool included
quantifying loss to follow-up across the multiple, linked
steps in the HIV care cascade, including (1) HIV testing,
(2) enrollment at an ART clinic for HIV-infected adults,
(3) CD4 testing post enrollment, (4) ART initiation among
eligible individuals, and (5) adhering to ART post ART ini-
tiation. The PCAT also quantifies the number of women
that would complete the entire HIV care cascade if drop-
off at each step were eliminated; this maximizing function
allows health workers to quickly prioritize steps along the
cascade to target for improvement.
In developing the PCAT, initial priorities included 1)
introduction of the steps specific to the pMTCT cascade;
2) adaptation of the interface for data entry by frontlinehealth managers using a broadly available program such
as Excel®; 3) creation of versions in English, French and
Portuguese; 4) ensuring the tool uses only data available
through the routine HMIS; and 5) an output design that
clearly indicates which individual improvement step
would lead to the largest overall efficiency gains across
the pMTCT cascade.
Process mapping techniques were used to chart PMTCT
cascade steps in five facilities, including ANC attendance,
HIV testing and counseling, provision of prophylactic
ARVs, safe delivery, safe infant feeding, infant follow-up
including HIV testing, and family planning, in order to
obtain site-specific knowledge of service delivery [4,27].
Women’s linkages into long-term HIV care and treatment
services, including eligibility assessment for cART and
cART initiation, were also considered as part of the
pMTCT cascade. Study teams worked with staff from
the ANC, maternity, postpartum, and at-risk child care
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of mother-infant pairs across these services. By working
with facility staff to explicitly describe the sequential,
linked processes of care delivery at their facility, key
steps in the pMTCT cascade were highlighted [28].
After mapping the pMTCT cascade, study staff con-
ducted discussions with health facility staff to refine the
objectives of the PCAT, identify users and beneficiaries,
and reach consensus on which steps of the pMTCT
cascade should be included based on data availability,
data quality, and their importance for achieving effective
pMTCT service delivery.
Initial versions of the PCAT (designed in Excel®) were
shared and discussed with 27 additional pMTCT managers
and frontline nurses, including at the provincial (4 people),
district (5 people from 3 districts), and facility levels (18
people from 10 health facilities). The tool was presented in
a series of 1–2 hour meetings in which its understandabil-
ity, usability, and appropriateness were discussed. Over the
following six months the PCAT was redesigned based on
continued stakeholder feedback, and pilot tested in five
health facilities with pMTCT services before its introduc-
tion. The iterative development process is described in
Table 1.
Results and discussion
The first version of the PCAT was described by pMTCT
managers as overly complex, requiring multiple data ma-
nipulations across multiple spreadsheets. Unlocked cells
led to inadvertent formula tampering. CD4 testing was
eliminated as a cascade step because the introduction of
new pMTCT norms no longer required CD4 testing to
determine cART or prophylactic ART eligibility [29].
Managers provided feedback that they preferred a tool
which they could independently manipulate without
technical guidance.
The PCAT evolved in a number of notable ways
(Figure 2). A total of seven cascade steps were included
to cover two connected parts of the cascade (pregnancy
through post-delivery, and delivery through infant follow-Table 1 PCAT tool development timeline
Activity
Initial planning meetings-researchers/program managers
Tool adaptation & development
Feedback meetings with program managers & frontline health workers
Tool revisions
Feedback meetings with program managers & frontline health workers
Tool revision
Feedback with program managers & frontline health workers
Tool introductionup). Prevalence calculations were included as sub-headings
under relevant steps. Cells that did not require data inputs
were locked and wording simplified. Font color, size and
other design changes were made to improve PCAT user-
friendliness.
Stepwise drop offs and maximization functions were in-
cluded in the key steps along the cascade. Maximization
functions were included for two different endpoints; for
steps 1–4, step 4 (the number of newborns receiving ARV
prophylaxis at the maternity) was the endpoint, while for
steps 5–7, step 7 (the number of eligible babies who initi-
ate ART) was the endpoint. While the drop off function
allows the health worker to rapidly assess how many
patients are lost at each step, the maximization function
describes how many additional people will be served if
only one step is improved to 100% capacity while others
stay the same.
After the second feedback meeting, the PCAT was fur-
ther simplified. The subsequent version was developed to
streamline commands, add custom functions, and simplify
the interface. Stakeholders universally preferred the re-
vised PCAT visually and functionally, and found the tool
to be easy-to-understand and useful. The final version of
the tool for use and adaptation is located in Annex 1.
A hypothetical example of the PCAT over a six-month
period is presented in Figure 2, based on a facility catch-
ment population of 100,000 and an estimated 5% preva-
lence of pregnancy. If the health facility reported 2,250
first ANC visits, then the tool will estimate that 90% of
the target catchment population is served (a drop-off of
250 women), and that if this step were maximized to
100% (from 90%) then an additional 23 newborns of HIV
infected mothers would receive prophylaxis at the mater-
nity (step 4). The coverage, drop off, and maximization is
quantified for each step along the cascade.
PCAT content
The PCAT allows frontline health managers to rapidly
quantify the drop off along the pMTCT cascade, and en-
ables managers to quickly and easily identify which stepMonth









Figure 2 PMTCT cascade analysis tool (screen shot).
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(tool available at: http://www.healthallianceinternational.
org/publications/presentations/).
Pregnancy through post-delivery
The first section of the PCAT begins at first ANC visit
and extends to the administration of prophylactic ARVs
for the newborn at the maternity. The initial four steps
include (1) number/proportion of 1st ANC visits (of those
births expected); (2) number/proportion of HIV tests ad-
ministered at the 1st ANC visit; (3) number/proportion of
women identified with HIV in the first ANC visit who
initiate cART or prophylaxis (PPO); and the (4) number/
proportion of newborns of HIV-infected mothers who re-
ceive prophylaxis at birth or shortly thereafter.
Post-delivery through ART initiation in children
The second cascade section begins post-delivery with
the first at-risk newborn consult through the administra-
tion of cART for eligible HIV-infected infants. The three
steps of this section of the cascade include (5) number/
proportion of first at-risk child visits among HIV-exposed
newborns; (6) number/proportion of enrolled children with
PCR tests completed prior to 8 weeks of life; and (7) num-
ber/proportion of eligible children initiating cART.
Step 1: Number of 1st ANC visits Data on the number
of first ANC visits from registries or facility reports is di-
vided by the target population to estimate the proportionof pregnant women accessing ANC. The drop off (or
added number gained if this step were to be maximized) is
calculated by subtracting the number of first ANC visits
from the estimated target population.
Step 2: Number of HIV tests at 1st ANC visit Data on
the number of women receiving HIV testing in first
ANC is entered to estimate the proportion of pregnant
women tested for HIV, with the number to be gained if
this step were improved calculated by subtracting the
number receiving an HIV test from the number of first
ANC visits. HIV testing data are located in ANC regis-
tries and in facility reports. HIV testing in subsequent
ANC visits are not included in this calculation, as its
objective is to model actual performance compared with
a fully functioning system. Although women are often
tested for HIV later in ANC, they would ideally be tested
at first visit to have time for comprehensive pMTCT
services prior to delivery. Therefore, the maximizing
function for this step assesses the number of additional
women who would be tested in first ANC visit should
this step be improved.
After entering the number of women tested for HIV,
the tool requires entering the number of HIV-infected
women identified, and automatically calculates HIV preva-
lence. Additional fields allow for entering the number of
women identified with HIV in prior pregnancies and sub-
sequent ANC visits to provide an accurate denominator
for further steps in the pMTCT cascade.
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total number of pregnant women initiating cART or
PPO over the relevant time period is entered, and the
proportion of HIV + women receiving an effective PPO
or cART during ANC is automatically calculated. If this
step were improved, the number of additional women
receiving PPO or cART is calculated by subtracting the
number receiving PPO or cART from the number of
HIV-infected women attending ANC. Required data are
available in ANC registries and monthly facility reports.
Step 4: Newborns of HIV + women receiving PPO
The number of newborns of HIV-infected mothers who
receive PPO at the maternity directly after birth is en-
tered and the proportion of newborns of HIV +mothers
receiving PPO at the maternity is automatically calcu-
lated. The number of additional HIV-exposed newborns
who would receive PPO if this step were maximized is
calculated by subtracting the number receiving PPO from
the total number of HIV-infected women in antenatal
care. Required data are available in maternity registries
and monthly facility reports.
Step 5: 1st at-risk child visits The number of HIV-
exposed children who enroll at at-risk child care is
entered to estimate the proportion of children born to
women identified with HIV in pregnancy who enter HIV
care. The number of additional HIV-exposed newborns
who would enroll in HIV care if this step were improved
is estimated by subtracting successfully enrolled children
from the overall number of children born to HIV-infected
women identified in ANC. These data are available in the
at-risk child consult registry which informs the monthly
facility level report and is subsequently entered into the
electronic HMIS.
Step 6: Babies in at-risk care who receive a PCR <8
weeks The number of children enrolled in at-risk care
who receive an HIV diagnosis via polymerase chain reac-
tion (PCR) by 8 weeks of life is entered to calculate the
proportion of enrollees with an early HIV diagnosis, and
estimate drop off in children who receive a HIV diagno-
sis according to recommendations if this step were im-
proved. Data on HIV diagnosis by PCR is captured via
clinic registries and monthly health facility level reports.
Subsequently, the number of HIV-infected newborns
identified through PCR testing within 8 weeks of life is
entered to calculate the proportion of HIV-infection in
tested infants, and provide a denominator for the last
cascade step.
Step 7: Eligible babies enrolled in cART The number
of children initiating cART is used to estimate the pro-
portion of eligible children initiating cART, and theadded number who would initiate cART if this step were
improved. These data are sourced from clinic registries
and monthly health facility reports.
Study procedures were approved by the Ethics Commit-
tee of the Mozambique Ministry of Health, and was deter-
mined to be non-research by the University of Washington
Institutional Review Board.
Conclusion
This paper describes the development process and content
of a systems analysis tool for pMTCT services (PCAT).
The PCAT is intended to be a decision-making support
tool for front line health workers and district managers by
providing a comprehensive understanding of their sys-
tems’ performance, covering ANC, delivery, and post-
partum care for mothers and their newborn children.
After iterative testing, the PCAT was streamlined to
capture key steps of the pMTCT cascade, be user-friendly
for stakeholders in resource-constrained environments,
and be used as adjunctive support for quality improvement
in pMTCT.
A primary strength of the PCAT is that it was designed
for use in settings with limited human and financial re-
sources and high HIV burden. By relying on routinely-
collected data (or data available through clinic registries),
the PCAT can be readily populated to provide a rapid
guide on where to intervene in the pMTCT cascade to
maximize the number of women and children receiving
successful pMTCT. The PCAT is open-source, available
in English, French and Portuguese, and is highly flexible
to meet the needs and context where it is intended to be
applied. The PCAT can use data collected over any dur-
ation (such as one month, six months or one year), or ag-
gregate the level of the health system (facility, district or
province) depending on the needs of the user. The PCAT
is meant to complement ongoing data quality audits as
well as facility-based quality improvement efforts, by en-
couraging health workers to incorporate improved admin-
istrative data into their decision-making.
Lessons learned through PCAT development
The PCAT development process and resulting tool pro-
vides a number of lessons learned that influence its use
for quality improvement efforts.
Maximizing function
Numerous papers have documented the use of cascade
drop off, specifically identifying the number of eligible
patients not receiving services by cascade step. However
the addition of the maximizing function provides health
facility managers with information on how many add-
itional people will be served if only one step is improved
to 100% capacity while others stay the same. This infor-
mation can be extremely helpful in identifying where in
Gimbel et al. BMC Research Notes 2014, 7:743 Page 7 of 8
http://www.biomedcentral.com/1756-0500/7/743the pMTCT cascade interventions to intervene. Al-
though not a panacea, the PCAT can be a powerful tool
for health facility managers who are most able to make a
difference in their workplace service flow.
Data quality
Because it will influence service delivery modifications,
the PCAT requires data of acceptable quality, which can
be a challenge in resource-constrained health systems
facing high HIV burden. For example, over- or under-
estimates of utilization may result from inaccurate
catchment population estimates. By engaging frontline
health workers and managers in PCAT implementation,
the process is designed to focus attention first on areas
of potential or actual poor data quality (such as unreal-
istic numbers), with the intention of improving data
quality. By acknowledging the poor quality of the data
they can go back to the registries to identify the source
of the discrepancy.
Making choices
To encourage its use, the tool was pared down to a
minimum number of steps within the PMTCT cascade.
Because the PCAT is designed to guide interventions in
pMTCT within ANC, maternity, and at-risk child visits,
these phases were included in the PCAT. Critical areas
such as family planning, linkages to long-term ART for
mom and baby, and community linkages were not in-
cluded. These are areas of great importance, which merit
further study and adaptation but were not within the
scope of this paper.
In addition, CD4 testing was not included in this cas-
cade for two reasons. With the advent of Option B+,
which places all HIV-infected mothers on ART regard-
less of CD4 levels, this measure is no longer a critical
entry step in the pMTCT cascade. In addition, a transi-
tion of partner support in the study area resulted in ex-
tremely limited data availability for this measure. As a
result, over half of the sites reported no available data,
which made beta testing untenable.
Shopping around
In large, urban areas with multiple health facilities, we
found that it is common for pregnant and post-partum
women to seek services at multiple facilities depending on
factors such as proximity, desire for anonymity, perceived
service quality, and availability of specialized services.
Thus, a woman may attend one facility for ANC, another
for birth and still another for at-risk care for newborns. As
a result, in urban areas the PCAT may under or over-
estimate service utilization across the pMTCT cascade at
the facility level. However, discussion based on the PCAT
can lead to an appreciation of these dynamics by facility
staff, and based on iterative application of the PCAT withquality improvement activities, the PCAT data may be-
come more accurate as retention improves at individual
facilities over time.
Shifting pMTCT strategies and forms
The PCAT development process coincided with the
introduction of the Option B + approach for pMTCT in
Mozambique, which changes the existing strategy to
initiate lifelong cART for pregnant women after HIV
diagnosis [30]. This change has simplified the PCAT by
eliminating CD4 as an entry barrier for cART or PPO.
Furthermore, new forms were introduced during PCAT
development, including MCH ‘passports’ that include lon-
gitudinal patient data for mothers and children, new clinic
registries and monthly reporting formats. In some in-
stances these modifications were designed to address needs
for patient-level care indicators and donor requirements
rather than systems strengthening efforts. An example of
this is the selection of the number of CD4 tests under 350
cells/mm3 rather than the total number of CD4 tests
carried out, which is an essential indicator for assessing
pMTCT system functioning prior to the introduction of
Option B+. The PCAT is sufficiently flexible to address
changes in clinical protocols and changes in reporting
format.
Our experience suggests that it is feasible and appro-
priate to adapt this cascade analysis tool for pMTCT
services at the health facility level as a starting point for
discussions of where to implement improvement strat-
egies. The resulting PCAT does not stand alone, but re-
quires engagement with frontline health workers and
managers to fill out, interpret and apply the tool, and
then follow up with QI activities. In addition, data quality
audit activities support the strengthening of the adminis-
trative source data. Further research on how to encourage
adoption, interpretation, and sustainability of the PCAT
by frontline health workers and managers is needed. How-
ever, the PCAT is available for application and further re-
finement, and provides a platform to improve the use of
data for decision-making as an interim step towards im-
proving service delivery and patient health outcomes.
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